Thrombocytopenia: Causes and Workup Topical Map
Complete topic cluster & semantic SEO content plan — 42 articles, 6 content groups ·
Build a definitive clinical resource covering what thrombocytopenia is, every major cause, and a step-by-step diagnostic workup that clinicians and informed patients can trust. Authority will be achieved by producing deep, guideline-aligned pillar articles (causes, diagnostic algorithms, management) supported by granular cluster pages (ITP, TTP, HIT testing, bone marrow biopsy indications, pregnancy, pediatrics, transfusion thresholds, etc.).
This is a free topical map for Thrombocytopenia: Causes and Workup. A topical map is a complete topic cluster and semantic SEO strategy that shows every article a site needs to publish to achieve topical authority on a subject in Google. This map contains 42 article titles organised into 6 topic clusters, each with a pillar page and supporting cluster articles — prioritised by search impact and mapped to exact target queries.
How to use this topical map for Thrombocytopenia: Causes and Workup: Start with the pillar page, then publish the 22 high-priority cluster articles in writing order. Each of the 6 topic clusters covers a distinct angle of Thrombocytopenia: Causes and Workup — together they give Google complete hub-and-spoke coverage of the subject, which is the foundation of topical authority and sustained organic rankings.
📋 Your Content Plan — Start Here
42 prioritized articles with target queries and writing sequence.
Fundamentals and Clinical Presentation
Defines thrombocytopenia, explains pathophysiology and clinical presentation, and clarifies when low platelets are an emergency — essential baseline content for clinicians and patients to contextualize causes and workup.
Thrombocytopenia Explained: Definition, Mechanisms, and Clinical Presentation
A comprehensive primer that defines thrombocytopenia, explains pathophysiological mechanisms (decreased production, increased destruction, sequestration, dilution), and maps how platelet levels correlate with bleeding risk and symptoms. Clinicians and informed patients will get clear guidance on symptom recognition, classification by severity, and red flags that require urgent evaluation.
When Is Thrombocytopenia an Emergency? Red Flags and Immediate Actions
Explains clinical signs that indicate life‑threatening bleeding or urgent conditions (TTP, DIC, intracranial hemorrhage) and outlines immediate bedside actions and initial labs that must be obtained.
How Low Is Too Low? Platelet Count Thresholds and Clinical Significance
Details platelet count ranges (mild, moderate, severe), associated bleeding risk, and typical management thresholds used in clinical practice and guidelines.
Clinical Presentation: Recognizing Signs and Symptoms of Low Platelets
Describes common mucocutaneous bleeding manifestations, systemic signs, and non-bleeding presentations (incidental lab finding), plus how history guides the differential.
Classification and Causes by Mechanism: A Practical Framework
Presents an actionable classification of thrombocytopenia by mechanism (production vs destruction vs sequestration vs dilution), with examples and diagnostic implications.
Platelet Biology 101: Production, Function, and Laboratory Markers
Covers megakaryocyte biology, platelet lifespan, common lab markers (MPV, immature platelet fraction), and how these inform cause and prognosis.
Causes and Differential Diagnosis
Exhaustive, evidence‑based catalog of causes (immune, thrombotic, infectious, drug-induced, marrow failure, pregnancy, hepatic disease, hypersplenism) with distinguishing features — provides the diagnostic differential clinicians need.
Causes of Thrombocytopenia: A Complete Differential Diagnosis and How to Distinguish Them
A deep, organized differential that groups causes mechanistically and clinically, highlights hallmark features for each diagnosis, and provides point‑of‑care clues and initial tests to separate similar presentations (e.g., ITP vs TTP vs DIC vs HIT). Essential for diagnostic accuracy.
Immune Thrombocytopenia (ITP): Causes, Diagnosis, and Key Clinical Features
Focused review of primary and secondary ITP, typical presentation, diagnostic exclusion strategy, and features that differentiate ITP from other causes.
Thrombotic Thrombocytopenic Purpura (TTP) and HUS: How to Recognize and Differentiate
Explains classic pentad, neurological and renal findings, role of ADAMTS13, and how to separate TTP/HUS from DIC and severe sepsis.
Disseminated Intravascular Coagulation (DIC) and Consumptive Coagulopathies
Covers clinical contexts (sepsis, obstetric catastrophe, malignancy), characteristic lab pattern, and distinguishing points from other thrombocytopenias.
Heparin‑Induced Thrombocytopenia (HIT): Timing, Risk Factors, and Clinical Clues
Describes typical onset timing (5–14 days), 4T score use, thrombotic risk, implicated heparin types, and initial diagnostic steps.
Bone Marrow Failure and Infiltrative Causes: Aplastic Anemia, MDS, Leukemia, and Metastatic Disease
Explains presentations suggesting marrow cause (pancytopenia, systemic symptoms), key tests, and when to proceed to bone marrow biopsy.
Drugs, Toxins, and Infections That Cause Low Platelets
Lists common drug culprits (including quinines, sulfonamides, linezolid), chemotherapy effects, and infectious causes (HIV, HCV, EBV, sepsis), with timing and diagnostic tips.
Hypersplenism, Liver Disease, and Dilutional Thrombocytopenia
Reviews how splenic sequestration and advanced liver disease cause chronic low platelets, plus the clinical context and imaging clues.
Pregnancy‑Related Thrombocytopenia: Gestational, Preeclampsia, and ITP in Pregnancy
Differentiates common pregnancy causes, timing in gestation, maternal and fetal risks, and peripartum management implications.
Diagnostic Workup and Laboratory Evaluation
Step-by-step diagnostic algorithms, lab test interpretation (CBC, smear, MPV, reticulated platelets, coagulation studies), and when to use specialized testing (ADAMTS13, HIT serology, bone marrow). This is the actionable core for clinicians.
Diagnostic Workup for Thrombocytopenia: Labs, Algorithms, and When to Biopsy
Provides evidence‑based diagnostic pathways from initial CBC to advanced testing, explains how to interpret peripheral smear and key lab patterns, and gives clear indications for bone marrow biopsy and ADAMTS13/HIT testing. Includes clinical decision tools and algorithms for urgent vs outpatient evaluation.
How to Interpret the Peripheral Blood Smear in Thrombocytopenia
Practical guide to smear findings that point to specific causes (schistocytes for TMA, platelet clumping pseudothrombocytopenia, giant platelets in ITP or Bernard-Soulier), with photo examples and pitfalls.
Using ADAMTS13 and the PLASMIC Score to Diagnose TTP Quickly
Explains the role of ADAMTS13 testing, limitations of turnaround time, and how PLASMIC score guides early treatment decisions pending results.
HIT Testing: When to Send ELISA, SRA, and How to Use the 4T Score
Details appropriate timing for HIT testing, interpretation of anti‑PF4 ELISA vs functional assays (SRA), and how to act on intermediate/low 4T scores.
When to Perform a Bone Marrow Biopsy for Thrombocytopenia
Gives clear indications, pre-biopsy evaluation, expected findings for marrow causes, and how biopsy results change management.
Essential Coagulation and Hemostasis Tests in Thrombocytopenia (PT/INR, PTT, Fibrinogen, D-dimer)
Explains which coagulation studies to order, typical patterns in DIC vs liver disease vs isolated thrombocytopenia, and interpretation caveats.
Distinguishing Pseudothrombocytopenia and Lab Artifacts from True Low Platelets
Covers causes of spurious low platelet counts (EDTA clumping), how to confirm with repeat EDTA-free samples or smear review, and avoiding unnecessary workups.
Diagnostic Algorithms: Stepwise Approach to New‑Onset and Chronic Thrombocytopenia
Ready-to-use flowcharts and decision trees for outpatient vs inpatient evaluation, showing tests and actions at each step.
Management and Treatment Strategies
Guideline-aligned treatment pathways for each major cause (ITP, TTP, DIC, HIT, marrow failure), emergency management of bleeding, transfusion guidance, and chronic therapy options — the clinical action center.
Treating Thrombocytopenia: Evidence‑Based Management for ITP, TTP, HIT, DIC and More
Comprehensive management guidance covering acute stabilization, first‑ and second‑line therapies for ITP, urgent treatment algorithms for TTP and DIC, HIT-specific anticoagulation, transfusion thresholds, and when to escalate to specialty care. Emphasizes guideline recommendations and real-world decision points.
ITP Management Pathway: When to Start Steroids, IVIG, and Next Steps for Refractory Disease
A practical algorithmic guide to treating ITP, including dosing, expected timelines, indications for second-line agents (rituximab, romiplostim, eltrombopag), and monitoring for side effects.
Urgent Management of TTP: Plasma Exchange, Steroids, Caplacizumab and Early Recognition
Details immediate steps for suspected TTP, rationale for plasma exchange, role of ADAMTS13 testing, and new therapies like caplacizumab.
Platelet Transfusion: Indications, Dosing, Risks and Special Considerations
Covers thresholds for transfusion in bleeding and non-bleeding patients, perioperative targets, dosing, transfusion reactions, and avoiding transfusion in immune causes when possible.
Managing HIT and Thrombosis in the Setting of Low Platelets
Explains stopping all heparin, starting alternative anticoagulants (argatroban, bivalirudin, fondaparinux), and timing for platelet recovery and long-term anticoagulation.
DIC Treatment in Critically Ill Patients: Source Control, Blood Products, and Supportive Care
Practical ICU-focused management: treat underlying cause, targeted blood product support, hemostatic agents, and monitoring strategies.
Antiplatelet and Anticoagulant Decisions When Platelets Are Low
Guidance on when to hold or continue anticoagulation/antiplatelet therapy, bridging strategies, and balancing thrombosis vs bleeding risk by platelet level and indication.
New and Emerging Therapies: TPO Receptor Agonists, Rituximab, and Biologics
Summarizes mechanisms, indications, efficacy, and safety of modern agents used in chronic or refractory thrombocytopenia.
Special Populations and Clinical Scenarios
Covers thrombocytopenia in pregnancy, children, oncology patients, liver disease, and perioperative settings — each with unique diagnostic and management modifications clinicians must know.
Thrombocytopenia in Special Populations: Pregnancy, Pediatrics, Oncology, Liver Disease and Surgical Patients
Targeted guidance for evaluating and managing thrombocytopenia in populations where physiology, risks, and treatment choices differ (pregnant patients, children, cancer patients receiving chemotherapy, those with liver disease, and preoperative patients). Includes obstetric and pediatric protocols.
Thrombocytopenia in Pregnancy: Diagnosis and Peripartum Management
Differentiates gestational thrombocytopenia, preeclampsia/HELLP, and ITP during pregnancy; gives peripartum platelet targets and treatment options that are safe in pregnancy.
Pediatric Thrombocytopenia and Childhood ITP: Approach and When to Refer
Discusses presentation of acute childhood ITP, indications for treatment, typical natural history, and when to involve pediatric hematology.
Chemotherapy‑Induced Thrombocytopenia: Prevention, Dose Modifications, and Use of TPO‑RAs
Guidance on anticipating nadirs, dose holds or reductions, platelet support strategies, and evidence for thrombopoietic agents in cancer patients.
Liver Disease and Hypersplenism: Chronic Thrombocytopenia Management and When to Treat
Explains mechanisms in cirrhosis, impact on procedures, and when to consider TPO agonists or splenic interventions.
Perioperative Management: Platelet Targets for Surgery and Procedures
Quick-reference platelet thresholds for common procedures (neuraxial anesthesia, major surgery, dental extraction) and pre-op optimization steps.
Prognosis, Follow‑Up, and Preventing Complications
Addresses bleeding risk stratification, monitoring strategies, prevention (vaccination, med avoidance), patient education, and referral criteria — necessary for long‑term care and outcomes.
Prognosis and Follow‑Up for Patients with Thrombocytopenia: Monitoring, Preventing Complications, and When to Refer
Covers short‑ and long‑term prognosis by cause, monitoring frequency, strategies to reduce bleeding risk (vaccinations before splenectomy, med review), and clear referral criteria and patient safety education topics.
Bleeding Risk and Monitoring Plans: How Often to Check Platelets and What to Watch For
Provides monitoring intervals for different severities and causes, signs of progressive bleeding, and modifications for anticoagulated patients.
Patient Safety and Education: Avoiding NSAIDs, When to Seek Emergency Care, and Lifestyle Precautions
Actionable patient-facing guidance on medication risks, home safety, and alarm symptoms that require immediate evaluation.
When to Refer: Hematology Referral Criteria and Urgent Transfer Triggers
Clear referral thresholds (severe or refractory thrombocytopenia, suspected TTP, unexplained cytopenias) and guidance for emergency transfer.
Long‑Term Outcomes: Chronic ITP, Relapse Risk, and Quality of Life Considerations
Summarizes prognosis data, recurrence rates by cause, and quality-of-life impacts for chronic disease.
Full Article Library Coming Soon
We're generating the complete intent-grouped article library for this topic — covering every angle a blogger would ever need to write about Thrombocytopenia: Causes and Workup. Check back shortly.
Strategy Overview
Build a definitive clinical resource covering what thrombocytopenia is, every major cause, and a step-by-step diagnostic workup that clinicians and informed patients can trust. Authority will be achieved by producing deep, guideline-aligned pillar articles (causes, diagnostic algorithms, management) supported by granular cluster pages (ITP, TTP, HIT testing, bone marrow biopsy indications, pregnancy, pediatrics, transfusion thresholds, etc.).
Search Intent Breakdown
👤 Who This Is For
AdvancedClinical content teams at academic hospitals, hematology fellows/attendings, hospital medicine groups, and advanced NP/PA bloggers who can produce guideline-aligned, citation-rich material.
Goal: Establish a definitive topical hub that ranks for diagnostic and management queries (e.g., 'thrombocytopenia workup', 'when to transfuse platelets', 'ADAMTS13 testing'), earns citations from guidelines and hospital intranets, drives referrals to specialty clinics, and supports CME/content partnerships.
First rankings: 3-6 months
💰 Monetization
High PotentialEst. RPM: $8-$30
The best angle is clinician-targeted clinical pathways and CME—these attract high-value sponsorships and conversions; patient-facing guides supplement traffic and ad revenue but monetize less per user.
What Most Sites Miss
Content gaps your competitors haven't covered — where you can rank faster.
- Clear, stepwise diagnostic algorithms that prioritize cost-effective lab sequencing (when to order ADAMTS13, HIT assays, bone marrow biopsy) are rarely presented with flowcharts and decision thresholds.
- Practical guidance on interpreting platelet indices (MPV, plateletcrit) and automated analyzer flags for pseudothrombocytopenia is undercovered.
- Actionable, scenario-based guidance for platelet transfusion thresholds across procedures (central line placement, lumbar puncture, neuraxial anesthesia, neurosurgery) with citations to guidelines is inconsistent across sites.
- Differentiated pathways for pediatric versus adult thrombocytopenia (including age-specific causes and vaccination-related ITP) are often missing or conflated.
- Management guidance for thrombocytopenia in pregnancy that integrates maternal treatment, fetal monitoring, and delivery planning is thin or overly general on most sites.
- Practical protocols for inpatient teams on monitoring trends, escalation triggers, and preventing diagnostic anchoring (e.g., mislabeling HIT) are scarce.
- Cost and turnaround-time comparisons for laboratory tests (PF4 immunoassay vs functional assays, local ADAMTS13 options) to guide clinicians in resource-limited settings are rarely published.
Key Entities & Concepts
Google associates these entities with Thrombocytopenia: Causes and Workup. Covering them in your content signals topical depth.
Key Facts for Content Creators
Thrombocytopenia prevalence in hospitalized patients is up to 20% depending on cutoffs and acuity.
High inpatient prevalence means clinical hospital medicine and critical care content can attract substantial clinical readership and referral traffic.
Immune thrombocytopenia (ITP) incidence in adults is approximately 2–4 per 100,000 person-years.
ITP is a common specific diagnosis searched by clinicians and patients — a dedicated cluster on ITP diagnosis and management will capture high-intent queries.
Thrombotic thrombocytopenic purpura (TTP) incidence is ~2–6 cases per million per year but has high mortality if untreated (>90%).
Although rare, TTP generates urgent search traffic and medicolegal risk; authoritative, guideline-aligned content targeting emergency diagnostics will be highly valuable and linkable.
Heparin-induced thrombocytopenia (HIT) occurs in ~1–5% of unfractionated heparin exposures and <1% with low-molecular-weight heparin.
HIT content drives clicks from anticoagulation, perioperative, and hospital medicine audiences and supports monetization via professional education and decision tools.
Bleeding risk increases sharply below 30 x10^9/L and spontaneous mucocutaneous bleeding is common under 20 x10^9/L.
Clear, evidence-based threshold content (when to transfuse, when to admit) answers urgent clinical questions and improves trust and engagement.
Gestational thrombocytopenia affects approximately 5–10% of pregnancies and is the most common cause of low platelets in pregnancy.
Obstetrics-focused content and patient-facing guides can attract large, low-competition traffic and referral volume from prenatal providers.
Common Questions About Thrombocytopenia: Causes and Workup
Questions bloggers and content creators ask before starting this topical map.
Why Build Topical Authority on Thrombocytopenia: Causes and Workup?
Thrombocytopenia spans common outpatient issues (mild low platelets) to life-threatening emergencies (TTP, HIT), producing high-intent clinical searches and referral opportunities. Building deep, guideline-aligned authority across causes and diagnostic workflows captures both clinician decision-support traffic and patient education demand, positioning a site to dominate niche queries and earn citations from guidelines and hospital networks.
Seasonal pattern: Year-round (evergreen), with modest increases around guideline updates and conference seasons (AHA/ASH/ISTH meeting months: November–December and July–August) when professionals search for summaries.
Content Strategy for Thrombocytopenia: Causes and Workup
The recommended SEO content strategy for Thrombocytopenia: Causes and Workup is the hub-and-spoke topical map model: one comprehensive pillar page on Thrombocytopenia: Causes and Workup, supported by 36 cluster articles each targeting a specific sub-topic. This gives Google the complete hub-and-spoke coverage it needs to rank your site as a topical authority on Thrombocytopenia: Causes and Workup — and tells it exactly which article is the definitive resource.
42
Articles in plan
6
Content groups
22
High-priority articles
~6 months
Est. time to authority
Content Gaps in Thrombocytopenia: Causes and Workup Most Sites Miss
These angles are underserved in existing Thrombocytopenia: Causes and Workup content — publish these first to rank faster and differentiate your site.
- Clear, stepwise diagnostic algorithms that prioritize cost-effective lab sequencing (when to order ADAMTS13, HIT assays, bone marrow biopsy) are rarely presented with flowcharts and decision thresholds.
- Practical guidance on interpreting platelet indices (MPV, plateletcrit) and automated analyzer flags for pseudothrombocytopenia is undercovered.
- Actionable, scenario-based guidance for platelet transfusion thresholds across procedures (central line placement, lumbar puncture, neuraxial anesthesia, neurosurgery) with citations to guidelines is inconsistent across sites.
- Differentiated pathways for pediatric versus adult thrombocytopenia (including age-specific causes and vaccination-related ITP) are often missing or conflated.
- Management guidance for thrombocytopenia in pregnancy that integrates maternal treatment, fetal monitoring, and delivery planning is thin or overly general on most sites.
- Practical protocols for inpatient teams on monitoring trends, escalation triggers, and preventing diagnostic anchoring (e.g., mislabeling HIT) are scarce.
- Cost and turnaround-time comparisons for laboratory tests (PF4 immunoassay vs functional assays, local ADAMTS13 options) to guide clinicians in resource-limited settings are rarely published.
What to Write About Thrombocytopenia: Causes and Workup: Complete Article Index
Every blog post idea and article title in this Thrombocytopenia: Causes and Workup topical map — 0+ articles covering every angle for complete topical authority. Use this as your Thrombocytopenia: Causes and Workup content plan: write in the order shown, starting with the pillar page.
Full article library generating — check back shortly.
This topical map is part of IBH's Content Intelligence Library — built from insights across 100,000+ articles published by 25,000+ authors on IndiBlogHub since 2017.
Find your next topical map.
Hundreds of free maps. Every niche. Every business type. Every location.